Dynamk Capital
North America, New York, United States, New York
Description
Venture fund focused entirely on Life Sciences Industrials - tools, technologies and services fundamental to biopharma.
Investor Profile
Dynamk Capital has backed more than 19 startups, with 0 new investments in the last 12 months alone. The firm has led 14 rounds, about 74% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in United States, Norway, Canada.
- Strong thematic focus on Biotechnology, Medical, Life Science.
Stage Focus
- Series A (58%)
- Seed (21%)
- Series B (16%)
- Series Unknown (5%)
Country Focus
- United States (84%)
- Norway (5%)
- Canada (5%)
- Switzerland (5%)
Industry Focus
- Biotechnology
- Medical
- Life Science
- Health Care
- Artificial Intelligence (Ai)
- Therapeutics
- Manufacturing
- Medical Device
- Bioinformatics
- Machine Learning
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Dynamk Capital frequently co-invest with?
What are some of recent deals done by Dynamk Capital?
Find More Investors Like Dynamk Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
